Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Orthopaedics Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Orthopaedics Other
    Rilonacept Approved in the EU for Cryopyrin-Associated Periodic Syndromes - (DGNews)
    Surgery Provides Modest Benefit Over Non-Surgical Treatment for Carpal Tunnel Syndrome - (DGNews)
    Denosumab Superior to Zoledronic Acid in Delaying Skeletal-Related Events in Breast Cancer With Bone Metastases: Presented at ECCO-ESMO - (DGDispatch)
    Bone Microarchitecture Analysis Predicts Spine Fractures Independently of Bone Mineral Density: Presented at ASBMR - (DGDispatch)
    Bone Geometry Analyses Add to Power of Bone Mineral Density in Predicting Fractures: Presented at ASBMR - (DGDispatch)

    News archive

     Recent webcasts/CME - Orthopaedics Other
    • Optimizing Bone Health Management in Multiple Myeloma
    • Update on DVT and PE in OB Gyn/Ortho Patients
      Considerations in Pharmacy Compounding and the Treatment of Spasticity
      Differential Diagnosis and Management of Autoimmune Neuromuscular Diseases: A Case-Based Approach
      Frailty

      Webcasts/CME archive

       Recent cases - Orthopaedics Other
        Clinical Experience of Novel Interconnected Porous Hydroxyapatite Ceramics for the Revision of Tumor Prosthesis: A Case Report
        Missed Diagnosis of Ankle Pseudoaneurysm Following Ankle Arthroscopy: A Case Report
        An Unusual Case of Finger Swelling: A Case Report
        Surgical Treatment of a Giant Tibial High-Grade Mixofibrosarcoma with Preservation of Limb Function: A Case Report
        Myoepithelioma Within the Carpal Tunnel: A Case Report and Review of the Literature

        Cases archive
          




        my personal edition > orthopaedics other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Pyridoxine May Reduce Carpal Tunnel Symptoms: Presented at AANP

        By Bonnie Darves

        ANAHEIM, CA -- July 3, 2003 -- A daily dose of pyridoxine HCl (vitamin B6) might relieve significantly the symptoms of carpal tunnel syndrome (CTS) soon after starting treatment, according to a new study presented here July 1 at the American Academy of Nurse Practitioners annual meeting.

        Use of pyridoxine is not associated with any toxic effects as are the treatments commonly used for treatment of CTS symptoms, such as high doses of nonsteroidal anti-inflammatory drugs (NSAIDs). Pyridoxine is also easier to use than is another standard treatment for CTS -- arm splints.

        "That is really the main point -- that there is no risk for non-Parkinson's patients in taking [pyridoxine]," said study author Gregory Holm, MD, an assistant professor of nursing and medicine at the University of South Florida, in Tampa, Florida, United States. "And if there is an effect, it will be seen within 3 weeks."

        Dr. Holm cautioned that pyridoxine is contraindicated in patients with neurologic disorders who take the drug levodopa.

        In the pilot study, the first part of a multicenter, randomized, double-blind clinical trial, the researchers compared the effects in 29 subjects treated with pyridoxine 200 mg daily and 31 with placebo who had similar severity of CTS at baseline, based on the Hold-Moody Carpal Tunnel Severity Scale. All subjects also received NSAIDs and night-splints.

        Patients in the pyridoxine group experienced a significant positive effect compared with the control group (P=.022). In those who achieved a response to pyridoxine, the effects were seen within 3 weeks of starting treatment, Dr. Holm said. Nonresponders did not experience improvement between Weeks 3 and 6.

        "If it is going to be effective, improvement will be seen within a few weeks. So if it isn't working at 6 weeks [of treatment], it's time to move on to other options], Dr. Holm said.


        [Study title: Effects of Pyridoxine on Carpal Tunnel Syndrome: A Randomized Clinical Trial Pilot Study. Poster 26]




        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send